Atossa Therapeutics, Inc.ATOSNASDAQ
Loading
Cash & Equivalents Over TimeContracting
Percentile Rank79
3Y CAGR-19.5%
5Y CAGR+41.1%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
-19.5%/yr
vs +108.5%/yr prior
5Y CAGR
+41.1%/yr
Recent deceleration
Acceleration
-128.0pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
5.6x
Strong expansion
Streak
3 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $71.08M | -19.6% |
| 2023 | $88.46M | -20.2% |
| 2022 | $110.89M | -18.7% |
| 2021 | $136.38M | +243.8% |
| 2020 | $39.66M | +212.5% |
| 2019 | $12.69M | +22.3% |
| 2018 | $10.38M | +43.8% |
| 2017 | $7.22M | +138.4% |
| 2016 | $3.03M | -18.5% |
| 2015 | $3.72M | - |